Product Information
LEVOBUNOLOL 0.5% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $2.8186 per ML under NDC 24208050505. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 4, 1994. Its Orange Book therapeutic-equivalence code is AT.
Strength
5 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208050505
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
LEVOBUNOLOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074326FDA Approved
3/4/1994
TE Code
AT
On Market Since
3/4/1994
Pharmacological Classes
Price Statistics
The NADAC for LEVOBUNOLOL 0.5% EYE DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8186 per ML |
|---|---|
| All-time high | $3.3594 (Apr 16, 2014) |
| All-time low | $0.4246 (Aug 23, 2017) |
| 52-week high | $2.8186 |
| 52-week low | $1.8724 |
| Median price | $2.1905 |
| Average price | $2.0670 |
| Largest weekly change | -62.1% (Aug 23, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 72% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levobunolol Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOBUNOLOL 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for LEVOBUNOLOL 0.5% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $2.8186 per ML (NDC 24208050505), effective Sep 30, 2026.
How has the price of LEVOBUNOLOL 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for LEVOBUNOLOL 0.5% EYE DROPS has held within roughly two percent of its current level. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVOBUNOLOL 0.5% EYE DROPS?
Since Nov 28, 2013, the NADAC for LEVOBUNOLOL 0.5% EYE DROPS has ranged from a low of $0.4246 (Aug 23, 2017) to a high of $3.3594 (Apr 16, 2014), with a median of $2.1905 per ML.
Are there cheaper alternatives to LEVOBUNOLOL 0.5% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOBUNOLOL 0.5% EYE DROPS, is $0.7930 per ML — about 72% below LEVOBUNOLOL 0.5% EYE DROPS.
Who manufactures LEVOBUNOLOL 0.5% EYE DROPS?
LEVOBUNOLOL 0.5% EYE DROPS (NDC 24208050505) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.